TherapeuticsMD IncTXMD
Price$2.03

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $3.3M+85.7% YoYTTM through 30 Jun 2026
Net Income -$217KTTM through 30 Jun 2026
Free Cash Flow $2.5MTTM through 30 Jun 2026

Margins

Current
EBITDA Margin-109.2%
Operating Margin-9,990.0%
Net Margin-6.6%

Returns

0.7%ROE
-0.6%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio3.02x
Net Debt-$8.4Mnet cash position
Cash & Equivalents$9.2M

Quality Metrics

Altman Z-Score-33.98
Piotroski F-Score5 / 9
FCF Margin76.5%
Earnings-Beat Rate25.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $3M
Diluted EPS-$0.02TTM
'21'22'23'24'25
FY2025: $-0.05

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.